As part of a mid-term strategy review, the European Commission has proposed some revisions in the areas of life sciences and biotechnology. These include steps to promote knowledge transfer by improving links between research organisations and industry, and the mobilisation of public and private funding. An example of the latter is the implementation of the Joint Technology Initiative on Innovative Medicine. The Commission will also encourage wide ranging informed debate on the risks and benefits in life sciences and biotechnology. Important issues include the use of human embryonic stem cells, animal cloning and genetic testing. The Commission will also ensure a sustainable contribution of modern biotechnology to agriculture. The Commission has dedicated funding of approximately EUR 8 billion in its seventh Framework Programme (2007-2013), EUR 6 billion to support health research and EUR 2 billion to support research into food, agriculture, fisheries and biotechnology.